Lp(a) for Men Over 40: The Executive's Guide to the Inherited Heart Risk Hiding in a Normal Cholesterol Panel
You can have a clean lipid panel, a respectable HDL, an LDL inside the "reference range," and still be quietly walking around with twice the cardiovascular risk of the man next to you. The reason is one blood marker that almost nobody on a standard executive medical has ever been tested for: lipoprotein(a), or Lp(a). For men over 40, this is the single most under-tested number in your cardiovascular profile — and as of the 2026 ACC/AHA dyslipidemia guideline, that's officially no longer acceptable.
What Lp(a) Actually Is — And Why Your Panel Doesn't Show It
Lp(a) is an LDL-like particle with a sticky extra protein, apolipoprotein(a), bolted onto it. That extra protein makes it more inflammatory, more thrombogenic, and far more atherogenic per particle than ordinary LDL. Think of it as LDL with a barbed hook attached — it doesn't just deposit cholesterol, it actively promotes clotting and arterial damage.
Critically, Lp(a) is almost entirely genetic. Your level was set by the age of five and barely moves with diet, exercise, or weight loss. Around one in five men over 40 carries an elevated level. Most of them have no idea, because the standard lipid panel ordered at an annual physical does not include it.
If you've ever read about a fit, lean executive in his late forties who dropped from a heart attack with "no risk factors," there's a strong chance high Lp(a) was sitting silently in the background.
Why Lp(a) Matters More for Men Over 40
By the time you're in your forties, your cardiovascular system has spent two decades being exposed to whatever lifetime burden of Lp(a) you inherited. The damage is cumulative. Modelling work from the lipid community suggests that elevated Lp(a) effectively adds the equivalent of 10–15 years of arterial ageing to your risk.
The Genetic Lock-In
Because Lp(a) is genetic, knowing your number doesn't just protect you — it protects your children. If your Lp(a) is high, your first-degree relatives (sons, daughters, siblings, parents) have a meaningful probability of carrying the same risk. The 2026 guidelines explicitly recommend cascade testing of family members once a high Lp(a) is identified in one member.
The Interaction With ApoB and CAC
Lp(a) doesn't operate in isolation. Its risk compounds with every other cardiovascular variable you have. Elevated ApoB on top of elevated Lp(a) is not additive — it is multiplicative. A high CAC score plus high Lp(a) is a five-alarm signal. This is why the executive cardio triad — ApoB, CAC, Lp(a) — is the only blood-and-imaging combination that actually gives you a real risk picture by your forties.
When to Test Lp(a) — And How Often
The answer for every man over 40 is the same: once, now, and that's it.
Lp(a) is so stable across a lifetime that a single measurement is enough for the vast majority of people. The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline, the European Atherosclerosis Society, and the National Lipid Association now all recommend universal testing in adults at least once.
The reasons most executives haven't been tested are simple: NHS GPs don't routinely order it, standard occupational health screens don't include it, and most private "executive medicals" still rely on outdated lipid panels. You have to ask for it specifically — or work with someone who knows to look.
How to Read Your Lp(a) Number
Lp(a) is reported in either nmol/L (the more accurate unit) or mg/dL. Always insist on nmol/L. The rough interpretation for men over 40:
- Under 75 nmol/L — low risk. You can essentially ignore this one variable and focus on the rest of your cardiovascular picture.
- 75–125 nmol/L — borderline. Tightens the case for aggressive ApoB control.
- 125–250 nmol/L — high. Roughly 40% higher lifetime ASCVD risk. You need a serious cardiovascular protocol.
- Above 250 nmol/L — very high. Risk is approximately doubled. This is the band where every other modifiable lever matters more, not less.
About one in five men over 40 will land in the high or very high band. If you're in that group, the message isn't panic — it's that the rest of your cardiovascular hygiene now has to be excellent rather than average.
The Executive Lp(a) Protocol
You cannot directly lower Lp(a) with diet, exercise, supplements, or any currently available consumer-grade intervention. That is not the same as saying nothing can be done. The protocol shifts from lowering Lp(a) to relentlessly lowering every other risk factor that compounds with it.
If Your Lp(a) Is High — What to Actually Do
The single highest-leverage move is to drive ApoB lower than the standard targets. For a man over 40 with elevated Lp(a), ApoB under 60 mg/dL is the working benchmark used by the preventive cardiology community. That typically means a statin, often paired with ezetimibe, sometimes with a PCSK9 inhibitor — clinically directed, not self-prescribed.
Get a CAC score. Lp(a) tells you genetic risk; CAC tells you what that risk has already done to your arteries. Together they make the case for how aggressive your treatment needs to be.
Lifestyle Levers That Still Matter
You cannot meaningfully lower Lp(a) by living well, but you can meaningfully lower your overall cardiovascular event risk. Three levers carry the most weight for executives:
- Eliminate visceral fat. It is the upstream driver of insulin resistance, inflammation, and ApoB elevation.
- Build cardiovascular fitness with zone 2 cardio. VO2 max is the single most powerful longevity marker and a partial buffer against the arterial damage Lp(a) accelerates.
- Stop nicotine in any form. Smoking and Lp(a) are a particularly destructive pairing.
Blood pressure, sleep, and alcohol all sit in the second tier — important, but secondary to the three above.
Emerging Therapies — Pelacarsen and Olpasiran
The first generation of Lp(a)-specific drugs is finally arriving. Pelacarsen, an antisense oligonucleotide, is in the phase 3 Lp(a)HORIZON trial with cardiovascular outcomes data expected in 2026. Olpasiran, an siRNA therapy, has produced sustained Lp(a) reductions of up to 100% in earlier-phase studies.
These will not be over-the-counter solutions. They will be prescribed agents reserved initially for those with both elevated Lp(a) and established or very high-risk cardiovascular disease. But for executives in their forties testing now, this is exactly the window where knowing your number positions you to access these therapies the moment they become clinically available.
Lp(a), CAC, and ApoB — How They Fit Together
If you take one mental model away from this article, take this one: ApoB tells you how many atherogenic particles are circulating right now, Lp(a) tells you how dangerous each of those particles is genetically, and CAC tells you what damage has already been done.
You need all three. An executive who has only ever had an LDL and total cholesterol checked is flying blind on the most important variable in their long-term health. The investment to fix this is one blood test, one scan, and a conversation with someone who knows what to do with the numbers.
FAQ
Can lifestyle lower Lp(a)?
Marginally and inconsistently. Some research suggests aggressive weight loss can move Lp(a) by 10–15%, but the change is small relative to genetic load. Do not rely on lifestyle to fix high Lp(a) — rely on it to lower every other risk factor that compounds with it.
Should I take niacin for high Lp(a)?
Niacin lowers Lp(a) modestly (around 20–30%) but the cardiovascular outcomes trials have been disappointing, and the side effect profile is not benign. Most preventive cardiologists no longer recommend it as a primary strategy. Your money is better spent on getting ApoB to target.
Should my children be tested?
Yes, if your Lp(a) is elevated. The 2026 guidelines explicitly endorse cascade testing of first-degree relatives. Knowing in their twenties gives them three decades of head start on the modifiable side of the equation.
Does TRT affect Lp(a)?
Testosterone replacement therapy has been shown to lower Lp(a) modestly in some studies, but TRT is not a treatment for high Lp(a) and should never be initiated for that reason alone. If you're considering TRT for legitimate reasons, knowing your free testosterone and Lp(a) together is the right starting point.
What does an Lp(a) test cost in the UK?
A private Lp(a) test typically costs £40–£80 standalone, or is included in any decent advanced lipid panel. Most NHS GPs will order it on request once you've made the case that you've never been tested — particularly if you have any family history of early cardiovascular events.
How does Lp(a) compare to a standard cholesterol panel?
A standard panel measures total cholesterol, LDL-C, HDL-C, and triglycerides. It does not measure Lp(a), ApoB, or particle number. For a man over 40 making real decisions about long-term cardiovascular risk, the standard panel is no longer enough.
The Bottom Line
Lp(a) is the inherited cardiovascular risk most men over 40 will never test for unless they ask. It is the missing third leg of the executive cardio triad alongside ApoB and CAC. You can't change the number you were born with, but knowing it changes everything about how aggressively you protect the next thirty years of your life.
If you're a high-performing man in your forties or fifties who has never had an Lp(a) drawn, the next step is straightforward: get tested, get the rest of your cardiovascular profile mapped properly, and build a protocol around the numbers. That's the work I do with executives in the Optimization programme — turning a fragmented picture of cardiovascular risk into a clear, actionable plan you can run for decades.
Book a consultation and let's find out what your number actually is.